Drug Topics

FEBRUARY 9, 2023

The use of biomarker profiles to guide asthma treatment decisions have not been well-studied.

467

467

PharmaVoice

FEBRUARY 9, 2023

FDA’s food program is in for a major overhaul — here’s why pharma should pay attention.

FDA 243

FDA 243

Drug Topics

FEBRUARY 9, 2023

Researchers evaluated how changes in USP labeling standards have affected adherence across multiple classes of drugs.

Labelling 467

Labelling 467

PharmaVoice

FEBRUARY 9, 2023

Bayer’s Bill Anderson and Astellas’ Naoki Okamura will be charged with setting the companies on growth trajectories for 2023.

130

130

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

FEBRUARY 9, 2023

XBB, a less severe but more contagious strain of COVID-19, has taken over as the dominant Omicron strain.

461

461

Fierce Healthcare

FEBRUARY 9, 2023

HHS releases new guidance implementing key Medicare drug rebate program rking Thu, 02/09/2023 - 16:01

111

111

Fierce Healthcare

FEBRUARY 9, 2023

Evernorth study: Risk of suicide on the rise among youth pminemyer Thu, 02/09/2023 - 13:39

111

111

Drug Topics

FEBRUARY 9, 2023

A lower level of education was associated with an increased risk for uncontrolled asthma, particularly in adults with non-atopic asthma and those who used inhaled corticosteroids daily.

247

247

Drug Store News

FEBRUARY 9, 2023

NCPA issued gratitude to Sens. Cantwell and Grassley for their efforts to "pull back the curtain on PBMs and push for FTC review of anticompetitive PBM practices.

106

106

PharmExec

FEBRUARY 9, 2023

Examining efforts to boost women representation on company boards.

105

105

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

European Pharmaceutical Review

FEBRUARY 9, 2023

Researchers have shown that a newly developed two-chamber setup (TCS) for containment investigations consisting of an emission and a detection chamber may predict highly potent active pharmaceutical ingredient (HPAPI) dustiness in a sealed system at different flow conditions. These different flow conditions include the plain diffusive transport and the diffusive transport with the oppositely directed convective flow of airborne particles of the safe surrogate substance acetaminophen (ACAM).

Compounding 105

Compounding Dosage 105

STAT

FEBRUARY 9, 2023

An inexpensive and easy-to-deliver intervention — a single dose of the antibiotic azithromycin — could sharply reduce the number of pregnant people in low- and middle-income countries who develop the life-threatening condition sepsis in childbirth, a study published Thursday reported. The results of an international trial , published in the New England Journal of Medicine, showed that administration of the antibiotic during labor cut the risk of the mother developing sepsis by abou

98

98

Pharmaceutical Commerce

FEBRUARY 9, 2023

As the range of treatment options for rheumatoid arthritis (RA) continues to grow and biosimilars are poised to enter the arena, the need for expert strategies to improve therapy selection and address the access, affordability, and adherence challenges patients face is coming into sharper focus.

98

98

Drug Store News

FEBRUARY 9, 2023

​​​​​​​The campaign features personal stories and images from Bausch + Lomb SightMatters community members during age-related macular degeneration month.

98

98

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

DiversifyRx

FEBRUARY 9, 2023

While COVID will be sticking around, many of the patient financial COVID benefits will be going away soon. The COVID-19 pandemic has brought about numerous changes in the way we live and access healthcare. The emergency COVID measures that are currently active now have an expiration date: May 11, 2023. This means that in just a matter of months, the benefits we’ve come to rely on may no longer be available.

Independent Pharmacies 98

Independent Pharmacies 98

STAT

FEBRUARY 9, 2023

WASHINGTON — Cigarette giant Reynolds American is calling on the Food and Drug Administration to crack down on manufacturers of disposable e-cigarettes, like Puff Bar and Elf Bar, which are increasingly being used by young people. The company, which also makes Vuse e-cigarettes, submitted a formal “citizen petition” to the FDA earlier this week calling on the agency to adopt an enforcement policy specifically targeted at disposable competitors to its products.

FDA 98

FDA 98

Fierce Healthcare

FEBRUARY 9, 2023

Chutes & Ladders—Duke lands a new CEO; Verily hires new CFO following lay offs aburky Thu, 02/09/2023 - 17:54

98

98

Drug Store News

FEBRUARY 9, 2023

A new club opening in La Vergne, Tenn., will mark the retailer’s expansion into its 19th state.

98

98

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

PharmExec

FEBRUARY 9, 2023

Health disparities brought on by racial bias remain quite prevalent in areas such as drug access, use of diagnostics, and representation in clinical trials, but society-jarring events in recent years have sparked renewed efforts by industry to tackle these issues with tangible and hopeful gains.

98

98

The Guardian - Pharmaceutical Industry

FEBRUARY 9, 2023

Big pharma has choices about where to make new investments and, increasingly it seems, it is not choosing Britain Another day, another warning from the pharmaceutical sector that ministers’ ambitions to make the UK “a life sciences superpower” are in danger of falling flat. The comments from Sir Pascal Soriot, chief executive of AstraZeneca, were different in one important respect, however.

98

98

Drug Store News

FEBRUARY 9, 2023

Pillsbury’s new Funfetti Popcorn is a sweet and crunchy treat with a Funfetti glaze and sprinkles.

98

98

STAT

FEBRUARY 9, 2023

When breast oncologists see new patients, one of their hopes is that the patient doesn’t have triple-negative breast cancer. The subtype is considered particularly dangerous, as it tends to grow and spread more aggressively than other types, and it has fewer effective treatment options. But a small new study suggests that help might come from an engineered virus.

Chemotherapy 98

Chemotherapy 98

Drug Store News

FEBRUARY 9, 2023

Native’s Curl Care line is formulated to enhance natural waves and minimize frizz without weighing down hair, the company said.

98

98

Fierce Healthcare

FEBRUARY 9, 2023

New hybrid provider Enabled Healthcare launches in Washington with a focus on older adults with chronic conditions agliadkovskaya Thu, 02/09/2023 - 13:59

98

98

Drug Store News

FEBRUARY 9, 2023

The Active Lash line was designed to ensure that consumers can wear the brand's lashes when working out or doing intense activities.

98

98

STAT

FEBRUARY 9, 2023

WASHINGTON — The Senate Judiciary Committee on Thursday passed legislation to prevent drug companies from gaming the patent system to delay competition from cheaper generics, but members in both parties said they still have concerns about the reforms. The measure also seeks to curb a practice of filing dozens of patents on drugs to forestall competition from generic drugs and biosimilars by restricting the number of patents that patent holders can contest.

97

97

European Pharmaceutical Review

FEBRUARY 9, 2023

Oral difelikefalin could potentially relieve the moderate-to-severe itching associated with notalgia paresthetica, according to a study published in the New England Journal of Medicine. Notalgia paresthetica is a nerve disorder characterised by a persistent itch in the upper back. To date, there are no US Food and Drug Administration (FDA)-approved treatments specifically targeting this disorder.

FDA 97

FDA 97

STAT

FEBRUARY 9, 2023

The Philips respiratory machine recall is a no-win situation for patients and doctors. But for the medical device giant’s longtime rivals and new competitors, business is looking up. “We think it will be difficult for Philips to regain all the share that they had,” said Margaret Kaczor, an analyst with William Blair who follows ResMed among other companies.

97

97

Pharmaceutical Technology

FEBRUARY 9, 2023

Teva Pharmaceutical Industries has reported $3.9bn revenue in the fourth quarter (Q4) of 2022, representing a 5% decline in US dollars or a 1% increase in local currency terms, from $4.1bn in the same quarter of the previous year. During the quarter, higher revenues from Anda, generic products in the Europe segment, AJOVY and AUSTEDO were partially offset by fewer revenues from COPAXONE, generic products and certain respiratory products in the North America segment.

96

96

The Checkup by Singlecare

FEBRUARY 9, 2023

As a pharmacist, you are likely well aware of what the Drug Enforcement Agency (DEA) calls your “corresponding responsibility” in section Title 21 of the Code of Federal Regulations. The law states that a pharmacist must only fill a prescription for a controlled substance when it is issued for a legit medical reason by a legitimate practitioner acting within the usual scope of their professional practice.

Controlled Substances 96

Controlled Substances Insurance Coverage Labelling Insurance 96

Pharmaceutical Technology

FEBRUARY 9, 2023

ReviR Therapeutics has signed a research collaboration and option-to-license agreement with Asieris Pharmaceuticals to discover new oncology therapeutics. The collaboration is aimed at discovering and developing new advanced treatments for genitourinary (GU) tumours as well as other related serious diseases using ReviR’s RNA-targeted technologies.

Communication 96

Communication 96

Drug Store News

FEBRUARY 9, 2023

A majority of the new items are under $10, and the retailer is putting a spotlight on clean products, as well as Black-owned and inclusive brands.

96

96

STAT

FEBRUARY 9, 2023

Just how alarming is bird flu? And did we learn enough from Covid-19 to be sensible about it? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Helen Branswell, STAT’s senior writer covering infectious disease, joins us to explain the sudden resurgence of a bird flu virus called H5N1 and why experts are watching the situation closely.

93

93